Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

BACKGROUND: The objective of this study was to conduct a cost-effectiveness evaluation of pemetrexed compared to docetaxel in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) for patients with predominantly non-squamous histology in the Spanish healthcare setting. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Asukai, Yumi, Valladares, Amparo, Camps, Carlos, Wood, Eifiona, Taipale, Kaisa, Arellano, Jorge, Cassinello, Alejo, Sacristán, José Antonio, Dilla, Tatiana
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841662/
https://www.ncbi.nlm.nih.gov/pubmed/20113499
http://dx.doi.org/10.1186/1471-2407-10-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841662/
https://www.ncbi.nlm.nih.gov/pubmed/20113499
http://dx.doi.org/10.1186/1471-2407-10-26

Ejemplares similares